Contract facts
FederalNo full NAICS 334516 intel page yet. Browse NAICS intelligence
LEASE WITH TESTING SYSMEX HEMATOLOGY is a federal award for Defense Health Agency held by Sysmex America, Inc. Estimated value $238K ($238K obligated). Current period of performance ends Aug 31, 2026. Last award drew 1 bidder. Place of performance: LINCOLNSHIRE IL.
Recompete timing
PublicCurrent PoP ends Aug 31, 2026 (10 days remaining). Agencies typically plan 12–18 months ahead — at 0.3 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordSysmex America, Inc — $97.4M obligated across 1,085 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT940625FE031?
HT940625FE031 (LEASE WITH testing SYSMEX hematology) is a Defense Health Agency award with a potential value of $238K, currently held by Sysmex America, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded HT940625FE031?
Defense Health Agency awarded HT940625FE031 to Sysmex America, Inc (potential $238K).
Who is the incumbent on HT940625FE031?
Sysmex America, Inc is the incumbent with $97.4M across 1085 related awards in SCOUT’s public footprint. The current period of performance ends Aug 31, 2026.
When does Sysmex America, Inc’s HT940625FE031 come up for recompete?
SCOUT tracks a period-of-performance end of Aug 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.